Imerys S.A.

IMYSF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenue$3,605$3,794$4,282$3,665
% Growth-5%-11.4%16.8%
Cost of Goods Sold$1,196$1,461$1,592$1,287
Gross Profit$2,409$2,333$2,690$2,378
% Margin66.8%61.5%62.8%64.9%
R&D Expenses$0$0$0$0
G&A Expenses$68$990$1,058$998
SG&A Expenses$68$1,773$1,058$998
Sales & Mktg Exp.$0$783$0$0
Other Operating Expenses$2,098$453$1,312$1,089
Operating Expenses$2,166$2,225$2,370$2,087
Operating Income$243$108$318$291
% Margin6.7%2.8%7.4%7.9%
Other Income/Exp. Net-$274-$38-$50-$40
Pre-Tax Income-$31$69$268$251
Tax Expense$62$60$91$68
Net Income-$95$51$237$240
% Margin-2.6%1.4%5.5%6.6%
EPS-1.120.0762.82.84
% Growth-1,579.5%-97.3%-1.4%
EPS Diluted-1.120.62.762.79
Weighted Avg Shares Out85868585
Weighted Avg Shares Out Dil85868686
Supplemental Information
Interest Income-$9$17$5$3
Interest Expense$70$41$38$41
Depreciation & Amortization$302$236$317$324
EBITDA$340$500$623$611
% Margin9.4%13.2%14.6%16.7%